Advertisement

Topics

FDA grants 2 designations to Enzyvant's Farber disease drug

06:06 EDT 25 Mar 2019 | SmartBrief

Enzyvant's Farber disease drug candidate RVT-801 was given fast-track and rare pediatric disease designations by the FDA. -More

Original Article: FDA grants 2 designations to Enzyvant's Farber disease drug

NEXT ARTICLE

More From BioPortfolio on "FDA grants 2 designations to Enzyvant's Farber disease drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...